Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PerkinElmer stock in Canada | $138.96

Own PerkinElmer shares in just a few minutes.

PerkinElmer is a diagnostics & research business based in the US. PerkinElmer stocks (PKI.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $138.96 – a decrease of 4.21% over the previous week. PerkinElmer employs 14,000 staff and has a trailing 12-month revenue of around $4.4 billion.

How to buy PerkinElmer stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PKI in this case.
  5. Research PerkinElmer stocks. The platform should provide the latest information available.
  6. Buy your PerkinElmer stocks. It's that simple.

How has Coronavirus impacted PerkinElmer's stock price?

Since the stock market crash in March caused by coronavirus, PerkinElmer's stock price has had significant positive movement.

Its last market close was $138.96, which is 33.18% up on its pre-crash value of $92.85 and 120.89% up on the lowest point reached during the March crash when the stocks fell as low as $62.91.

If you had bought $1,000 worth of PerkinElmer stocks at the start of February 2020, those stocks would have been worth $730.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,496.60.

PerkinElmer stock price

Use our graph to track the performance of PKI stocks over time.

PerkinElmer stocks at a glance

Information last updated 2021-06-10.
Latest market close$138.96
52-week range$92.7267 - $162.539
50-day moving average $138.8737
200-day moving average $138.2821
Wall St. target price$158.5
PE ratio 15.2771
Dividend yield $0.28 (0.2%)
Earnings per share (TTM) $9.564

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Deposit and trade $100 and get a $50 bonus.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Is it a good time to buy PerkinElmer stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

PerkinElmer price performance over time

Historical closes compared with the last close of $138.96

1 month (2021-05-14) -3.20%
3 months (2021-03-16) 10.32%
6 months (2020-12-16) -1.31%
1 year (2020-06-16) 40.53%
2 years (2019-06-14) 49.52%
3 years (2018-06-15) 78.52%
5 years (2016-06-16) 163.53%

Is PerkinElmer under- or over-valued?

Valuing PerkinElmer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PerkinElmer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PerkinElmer's P/E ratio

PerkinElmer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, PerkinElmer stocks trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.

PerkinElmer's PEG ratio

PerkinElmer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7545. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PerkinElmer's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

PerkinElmer's EBITDA

PerkinElmer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.7 billion.

The EBITDA is a measure of a PerkinElmer's overall financial performance and is widely used to measure a its profitability.

PerkinElmer financials

Revenue TTM USD$4.4 billion
Operating margin TTM 32.04%
Gross profit TTM USD$2.1 billion
Return on assets TTM 11.73%
Return on equity TTM 31.76%
Profit margin 24.19%
Book value $35.714
Market capitalisation USD$16.4 billion

TTM: trailing 12 months

How to short and sell PerkinElmer stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "PKI.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 4.5 million PerkinElmer stocks held short by investors – that's known as PerkinElmer's "short interest". This figure is 12.7% up from 4.0 million last month.

There are a few different ways that this level of interest in shorting PerkinElmer stocks can be evaluated.

PerkinElmer's "short interest ratio" (SIR)

PerkinElmer's "short interest ratio" (SIR) is the quantity of PerkinElmer stocks currently shorted divided by the average quantity of PerkinElmer stocks traded daily (recently around 932319.13580247). PerkinElmer's SIR currently stands at 4.86. In other words for every 100,000 PerkinElmer stocks traded daily on the market, roughly 4860 stocks are currently held short.

However PerkinElmer's short interest can also be evaluated against the total number of PerkinElmer stocks, or, against the total number of tradable PerkinElmer stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PerkinElmer's short interest could be expressed as 0.04% of the outstanding stocks (for every 100,000 PerkinElmer stocks in existence, roughly 40 stocks are currently held short) or 0.0518% of the tradable stocks (for every 100,000 tradable PerkinElmer stocks, roughly 52 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against PerkinElmer.

Find out more about how you can short PerkinElmer stock.

PerkinElmer's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like PerkinElmer.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

PerkinElmer's total ESG risk score

Total ESG risk: 21.66

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and PerkinElmer's overall score of 21.66 (as at 01/01/2019) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like PerkinElmer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

PerkinElmer's environmental score

Environmental score: 3.15/100

PerkinElmer's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

PerkinElmer's social score

Social score: 12.09/100

PerkinElmer's social score of 12.09 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

PerkinElmer's governance score

Governance score: 9.42/100

PerkinElmer's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that PerkinElmer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

PerkinElmer's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. PerkinElmer scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that PerkinElmer has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

PerkinElmer, Inc was last rated for ESG on: 2019-01-01.

Total ESG score 21.66
Total ESG percentile 24.92
Environmental score 3.15
Environmental score percentile 4
Social score 12.09
Social score percentile 4
Governance score 9.42
Governance score percentile 4
Level of controversy 2

PerkinElmer stock dividends


Dividend payout ratio: 3.02% of net profits

Recently PerkinElmer has paid out, on average, around 3.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.2% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PerkinElmer shareholders could enjoy a 0.2% return on their shares, in the form of dividend payments. In PerkinElmer's case, that would currently equate to about $0.28 per share.

While PerkinElmer's payout ratio might seem low, this can signify that PerkinElmer is investing more in its future growth.

PerkinElmer's most recent dividend payout was on 6 August 2021. The latest dividend was paid out to all shareholders who bought their stocks by 15 July 2021 (the "ex-dividend date").

Have PerkinElmer stocks ever split?

PerkinElmer stocks were split on a 2:1 basis on 4 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your PerkinElmer stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for PerkinElmer stocks which in turn could have impacted PerkinElmer's stock price.

PerkinElmer stock price volatility

Over the last 12 months, PerkinElmer's stocks have ranged in value from as little as $92.7267 up to $162.539. A popular way to gauge a stock's volatility is its "beta".

PKI.US volatility(beta: 1.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while PerkinElmer's is 1.1082. This would suggest that PerkinElmer's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

PerkinElmer overview

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site